Advertisement
Grab your lab coat. Let's get started
Welcome!
Welcome!
Create an account below to get 6 C&EN articles per month, receive newsletters and more - all free.
It seems this is your first time logging in online. Please enter the following information to continue.
As an ACS member you automatically get access to this site. All we need is few more details to create your reading experience.
Not you? Sign in with a different account.
Not you? Sign in with a different account.
ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
People
Dow’s Ester Baiget to lead Novozymes
by Melody M. Bomgardner
November 2, 2019
| A version of this story appeared in
Volume 97, Issue 43
Ester Baiget will become CEO of the Danish enzyme company Novozymes on Feb. 1. She will join the firm from Dow, where she is president of the industrial solutions business. In that role, Baiget expanded Dow’s market share and delivered double-digit growth and strong earnings, Novozymes says. It announced last month that CEO Peter Holk Nielsen would step down as part of an effort to reignite growth at the firm, which has struggled with demand and earnings shortfalls in recent quarters.
The power is now in your (nitrile gloved) hands
Sign up for a free account to get more articles. Or choose the ACS option that’s right for you.
Already have an ACS ID? Log in
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X